Cargando…

Safety and efficacy of biological therapy with TNF-inhibitors and non TNF-inhibitors in a cohort of young adults affected by juvenile idiopathic arthritis (JIA): data from a single centre experience

Detalles Bibliográficos
Autores principales:	Lorenzo, Ceri, Fernanda, Falcini, Ginevra, Fiori, Serena, Capannini, Marco, Matucci Cerinic
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194639/ http://dx.doi.org/10.1186/1546-0096-9-S1-P273

Ejemplares similares

Temporomandibular joint involvement (TMJ), a silent disease with severe alterations in young adulthood patients affected by juvenile idiophatic arthritis (JIA)
por: Fernanda, Falcini, et al.
Publicado: (2011)

Longitudinal evaluation of bone mass in adolescents and young adults with juvenile idiopathic arthritis: the role of bone mass determinants in a large cohort of patients
por: Fernanda, Falcini, et al.
Publicado: (2011)

Comparison of bone mass and quality determinants in adolescents and young adults with juvenile systemic lupus erythematosus (JSLE) and juvenile idiopathic arthritis (JIA)
por: Falcini, Fernanda, et al.
Publicado: (2014)

Bone mass predictors in a large cohort of children with juvenile idiopathic arthritis (JIA)
por: Falcini, FF, et al.
Publicado: (2008)

Cross-sectional evaluation of bone mass in young adults with Juvenile Onset Systemic Lupus Erythematosus: the role of bone mass determinants in a large cohort of patients
por: Fernanda, Falcini, et al.
Publicado: (2011)

Anakinra in systemic juvenile idiopathic arthritis (soJIA) non responsive to antiTNF
por: Pontikaki, I, et al.
Publicado: (2008)

TNF inhibitors in the treatment of uveitis in the course of juvenile idiopathic arthritis
por: Opoka-Winiarska, Violetta, et al.
Publicado: (2014)

Effectiveness and safety of TNF inhibitors in adults with juvenile idiopathic arthritis
por: Kearsley-Fleet, Lianne, et al.
Publicado: (2016)

Efficacy of a second TNF blocker, when the first one failed, in patients with juvenile idiopathic arthritis (JIA)
por: Salmaso, A, et al.
Publicado: (2008)

PReS-FINAL-2315: Severe cutaneous vasculitis in two patients with juvenile idiopathic arthritis and biologic therapy
por: Falcini, F, et al.
Publicado: (2013)

Patients with juvenile idiopathic arthritis on TNF inhibitors exposed to COVID-19 family members
por: Marino, Achille, et al.
Publicado: (2020)

Pregnancy outcomes in women affected by juvenile idiopathic arthritis (JIA)
por: Alpigiani, Maria Giannina, et al.
Publicado: (2014)

Talus Arthritis Pattern in Juvenile Idiopathic Arthritis (JIA)
por: Alkhreisat, Mohammad, et al.
Publicado: (2019)

Ocular threat in juvenile idiopathic arthritis (JIA)
por: Marvillet, I, et al.
Publicado: (2008)

Effectiveness of tnf inhibitors therapy in children with juvenile idiopathic arthritis aged 2 to 5 years
por: Opoka-Winiarska, Violetta, et al.
Publicado: (2014)

Efficacy and safety of TNF inhibitors in the treatment of juvenile idiopathic arthritis: a systematic literature review
por: Horneff, Gerd, et al.
Publicado: (2023)

Study of vitamin D status and vitamin D receptor polymorphisms in a cohort of Italian patients with juvenile idiopathic arthritis
por: Marini, Francesca, et al.
Publicado: (2020)

Juvenile idiopathic arthritis (JIA) in two tertiary centres in the Western Cape, South Africa
por: Weakley, Kate, et al.
Publicado: (2011)

PReS-FINAL-2044: TNF-alpha inhibitors in treatment of children with systemic form of juvenile idiopathic arthritis
por: Zholobova, ES, et al.
Publicado: (2013)

Mandibular condyle destruction in juvenile idiopathic arthritis (JIA)
por: Zak, M, et al.
Publicado: (2008)

Therapeutic drug monitoring of anti-TNF drugs: an overview of applicability in daily clinical practice in the era of treatment with biologics in juvenile idiopathic arthritis (JIA)
por: Nassar-Sheikh Rashid, A., et al.
Publicado: (2021)

PReS-FINAL-2053: Vitamin D receptor polymorphisms in a cohort of Italian patients with juvenile idiopathic arthritis
por: Falcini, F, et al.
Publicado: (2013)

Tuberculosis in Juvenile Idiopathic arthritis under Anti-TNF therapy
por: Espada, G, et al.
Publicado: (2011)

Anti-TNF therapy for juvenile idiopathic arthritis-related uveitis
por: Semeraro, Francesco, et al.
Publicado: (2014)

Mycophenolate Mofetil (MMF) for the treatment of juvenile onset systemic lupus erythematosus
por: Falcini, FF, et al.
Publicado: (2008)

Adalimumab and severe uveitis in juvenile idiopathic arthritis (JIA) therapy
por: Alpigiani, MG, et al.
Publicado: (2008)

Infliximab to treat chronic uveitis in juvenile idiopathic arthritis (JIA)
por: Bracaglia, C, et al.
Publicado: (2008)

Thalidomide: efficacy and side effects in juvenile idiopathic arthritis (JIA)
por: Alpigiani, MG, et al.
Publicado: (2008)

Juvenile idiopathic arthritis (JIA): can an integrated medicine be possible?
por: Officioso, A, et al.
Publicado: (2011)

Sport and exercise habits in children with juvenile idiopathic arthritis (JIA)
por: Nørgaard, M, et al.
Publicado: (2011)

Bone mass and quality in patients with juvenile idiopathic arthritis: longitudinal evaluation of bone-mass determinants by using dual-energy x-ray absorptiometry, peripheral quantitative computed tomography, and quantitative ultrasonography
por: Stagi, Stefano, et al.
Publicado: (2014)

The effects of TNF-alpha inhibitor therapy on the incidence of infection in JIA children: a meta-analysis
por: Nagy, Arnold, et al.
Publicado: (2019)

Sleep, fatigue and quality of life in juvenile idiopathic arthritis (JIA) and Juvenile Dermatomyositis (JDM)
por: Avie, Y Butbul, et al.
Publicado: (2008)

Time of onset of iridocyclitis (IC) in children with juvenile idiopathic arthritis (JIA)
por: Verazza, S, et al.
Publicado: (2008)

Rituximab in ANA positive polyarticular juvenile idiopathic arthritis (JIA) with uveitis
por: Baildam, EM, et al.
Publicado: (2008)

Replication of the association of the COG6 gene with juvenile idiopathic arthritis (JIA)
por: Hinks, A, et al.
Publicado: (2011)

Dynamic knee joint function in children with juvenile idiopathic arthritis (JIA)
por: Hansmann, Sandra, et al.
Publicado: (2015)

TNF-α Polymorphisms in Juvenile Idiopathic Arthritis: Which Potential Clinical Implications?
por: Scardapane, A., et al.
Publicado: (2012)

Concerted Actions by PIICP, CTXII, and TNF-α in Patients with Juvenile Idiopathic Arthritis
por: Winsz-Szczotka, Katarzyna, et al.
Publicado: (2021)

Discontinuation rates of biologics in patients with rheumatoid arthritis: are TNF inhibitors different from non-TNF inhibitors?
por: Ramiro, Sofia, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ttbpra5r6b9a8fl75lbmcvehil